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ell cycle progression is driven by waves of cyclin ex-
pression coupled with regulated protein degradation.
An essential step for initiating mitosis is the inactiva-
tion of proteolysis mediated by the anaphase-promoting
complex/cyclosome (APC/C) bound to its regulator Cdh1p/
 
Hct1p. Yeast APC
 
Cdh1
 
 was proposed previously to be inacti-
 
vated at Start by G1 cyclin/cyclin-dependent kinase (CDK).
 
Here, we demonstrate that in a normal cell cycle APC
 
Cdh1
 
 is
C
 
inactivated in a graded manner and is not extinguished until
S phase. Complete inactivation of APC
 
Cdh1
 
 requires S phase
cyclins. Further, persistent APC
 
Cdh1
 
 activity throughout G1
helps to ensure the proper timing of Cdc20p expression.
This suggests that S phase cyclins have an important role in
allowing the accumulation of mitotic cyclins and further
suggests a regulatory loop among S phase cyclins, APC
 
Cdh1
 
,
and APC
 
Cdc20
 
. 
 
Introduction
 
The anaphase-promoting complex/cyclosome (APC/C)* is a
conserved multi-component ubiquitin ligase, which controls
the proteolysis of several key cell cycle proteins (Irniger et
al., 1995; King et al., 1995; Sudakin et al., 1995; Tugend-
reich et al., 1995; for reviews see Peters, 1999; Zachariae and
Nasmyth, 1999). In budding yeast, these include at least
four of the six yeast B-type cyclins (Clb1p–Clb3p and
Clb5p) (Irniger et al., 1995; Irniger and Nasmyth, 1997;
Schwab et al., 1997), Dbf4, a regulator of DNA replication
(Cheng et al., 1999; Oshiro et al., 1999; Ferreira et al.,
2000), the anaphase inhibitor Pds1p (Cohen-Fix et al.,
1996), the polo-like kinase Cdc5p (Charles et al., 1998), the
APC/C regulator Cdc20p (Prinz et al., 1998; Shirayama et
al., 1998), the checkpoint kinase Hsl (Burton and Solomon,
2000), and the spindle midzone protein Ase1p (Juang et al.,
1997). The tryptophan aspartic acid repeat proteins Cdc20p
and Cdh1p/Hct1p are substoichiometric APC/C compo-
nents that are proposed to be substrate-specific APC/C acti-
vators (Schwab et al., 1997; Visintin et al., 1997). Based on
its association with either of these two activators, the APC/C
 
is thought to have two functionally distinct forms: APC
 
Cdc20
 
and APC
 
Cdh1
 
 (Peters, 1998).
To coordinate a normal cell cycle, these two APC/C activ-
ities must be linked either directly or indirectly to cyclin-
dependent kinase (CDK) activity. For APC
 
Cdh1
 
, the linkage
is thought to take place primarily through CDK phosphoryla-
tion of Cdh1p. In yeast, Cdh1p levels are constant through-
out the cell cycle, but its binding to APC/C is blocked by
CDK phosphorylation (Zachariae et al., 1998; Jaspersen et
al., 1999). At the end of mitosis, APC
 
Cdh1
 
 is activated be-
cause Cdh1p is dephosphorylated and binds APC/C. Both
the drop in mitotic kinase activity and the activation of the
phosphatase Cdc14p contribute to Cdh1p dephosphoryla-
tion during mitotic exit (Visintin et al., 1998; Shou et al.,
1999). Eventually, APC
 
Cdh1
 
 is inactivated in the next cell cy-
cle by rising CDK activity. However, the precise timing of
APC
 
Cdh1
 
 inactivation and the CDK isoforms involved have
not been determined clearly. The experimental evidence to
date supports the view that G1 CDKs alone inactivate what
is now known to be APC
 
Cdh1
 
 (Amon et al., 1994). Addition-
ally, the possibility that S phase cyclins could have a role in
APC
 
Cdh1
 
 inactivation has been raised because failure to de-
grade an S phase cyclin by the end of mitosis can block
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APC
 
Cdh1
 
 function and mitotic exit (Shirayama et al., 1999;
Zachariae and Nasmyth, 1999).
During G1, APC
 
Cdh1
 
 activity is required to prevent ex-
pression of proteins that may interfere with bud emergence,
lead to premature DNA replication, or disturb spindle as-
sembly (Amon et al., 1994; Irniger and Nasmyth, 1997;
Juang et al., 1997). Before the onset of the ensuing mitosis,
APC
 
Cdh1
 
 must be turned off in order to allow its mitotic
substrates to accumulate. Several lines of evidence linked G1
CDK activity (Cln1p-Cln3p bound to Cdk1p) to the inacti-
vation of APC
 
Cdh1
 
. First, in 
 
cdc4
 
-arrested cells, which block
in late G1 with high levels of G1 CDK activity, ectopically
expressed M phase B-type cyclin Clb2p was stable, and its
stability required the expression of G1 cyclins (Amon et al.,
1994; Amon, 1997). Second, the accumulation of a consti-
tutively expressed Clb2p correlated with the rise in G1 cy-
clin expression that occurs in G1 (Amon et al., 1994). Fi-
nally, Cdh1p was heavily phosphorylated and presumed to
be inactive in late G1-arrested cells (Zachariae et al., 1998).
Together, these experiments suggested that G1 CDK phos-
phorylation of Cdh1p was the mechanism for inactivating
APC
 
Cdh1
 
. However, these experiments were potentially com-
plicated by the fact that Clb2p is not only an APC/C sub-
strate but also an APC/C regulator whose expression might
influence its own stability (Amon, 1997).
Unexpectedly, we found that another APC
 
Cdh1
 
 substrate,
the microtubule-binding protein Ase1p, was rapidly de-
graded in late G1 (
 
cdc4
 
 block). Further, Ase1p degradation
at this arrest point had the hallmarks of APC
 
Cdh1
 
-dependent
proteolysis: it required both the Ase1p destruction box and
Cdh1p. A minimal Ase1p sequence for APC
 
Cdh1
 
-mediated
degradation was defined whose constitutive expression did
not affect cell cycle progression. Using this degradation sig-
nal to monitor APC
 
Cdh1
 
 activity in vivo, we found that
APC
 
Cdh1
 
 is inactivated during S phase and that the S phase
cyclin Clb5p was required for the normal timing of APC
 
Cdh1
 
inactivation. Further, we show that the degradation of
Cdc20p in late G1 is also APC
 
Cdh1
 
 dependent and that pre-
mature expression of Cdc20p delays the progression through
S phase. These findings suggest that both G1 and S phase
cyclins are required to shut off APC
 
Cdh1
 
 and that APC
 
Cdh1
 
activity in G1 plays an important role in ensuring the proper
timing of Cdc20p expression.
 
Results
 
In budding yeast, genetic and biochemical analyses have de-
fined several molecular events necessary for transit through
G1 and into S phase. CDK activity is low in early G1 but
rises in late G1 when G1 cyclins are expressed. The rise in
G1 CDK activity induces apical bud growth and initiates a
cascade of events that leads to the phosphorylation and sub-
sequent degradation of the B-type cyclin/CDK inhibitor
Sic1p. Sic1p degradation permits the activation of S phase
CDKs (Cdk1p bound to Clb5p and Clb6p, two of the six
B-type cyclins in yeast) and therefore the initiation of S
phase (for review see Krek, 1998).
To determine if Ase1p destruction was inactivated by G1
CDK activity, the half-life of Ase1p was determined in a
 
cdc4
 
 mutant, which arrests before S phase with high G1
CDK activity and high levels of Sic1p. We found that Ase1p
is rapidly degraded at the 
 
cdc4
 
 block with similar kinetics to
that observed previously in 
 

 
-factor–arrested cells (Fig. 1 A;
Juang et al., 1997). The 5–10 min half-life of Ase1p at the
 
cdc4
 
 arrest point contrasts sharply with the 
 

 
60 min half-
life of Ase1p observed in cycling or nocodazole-arrested cells
(Juang et al., 1997; data not shown). Ase1p is also rapidly
degraded in a 
 
skp1-11
 
 strain, which also arrests in late G1
(data not shown). This also contrasts with the degradation
of the APC
 
Cdh1
 
 substrate Clb2p, which is stable at the 
 
cdc4
 
block (Amon et al., 1994; Amon, 1997; unpublished data;
see Fig. 4 B, glu). Like Ase1p degradation in 
 

 
-factor–
arrested cells, Ase1p degradation at the 
 
cdc4
 
 block required
Cdh1p and the destruction box (db), a cis-acting sequence
for APC/C-mediated degradation (Fig. 1, A and B). There-
fore, Ase1p is rapidly degraded by APC
 
Cdh1
 
 in the presence
of high levels of G1 CDK activity.
The rapid degradation of Ase1p in 
 
cdc4
 
-arrested cells
prompted us to determine if Cdh1p could bind APC/C in
 
cdc4
 
-arrested cells. Unphosphorylated Cdh1p binds to APC/
C strongly, whereas CDK-phosphorylated Cdh1p does not
(Zachariae et al., 1998; Jaspersen et al., 1999). Cdh1p was
found previously to be heavily phosphorylated in cells ar-
rested in late G1 (Zachariae et al., 1998). We also found
that Cdh1p appears to be phosphorylated in 
 
cdc4
 
-arrested
cells, although judging from its mobility it appears to be less
phosphorylated than in nocodazole-arrested cells (Fig. 1 C,
input). Consistent with the apparent activity of APC
 
Cdh1
 
 at
the 
 
cdc4
 
 block, Cdh1p was coimmunoprecipitated with
APC/C in 
 
cdc4
 
-arrested cells. The coimmunoprecipitation
experiments suggest that the amount of APC
 
Cdh1
 
 diminishes
in a graded manner during G1: high levels of Cdh1p coim-
munoprecipitate with Cdc16p in 
 

 
-factor–arrested cells, low
levels of Cdh1p coimmunoprecipitate in 
 
cdc4
 
-arrested cells,
and coimmunoprecipitation is undetectable in nocodazole-
arrested cells (Fig. 1 C).
Many of the known APC/C substrates are also APC/C
regulators (Amon, 1997; Charles et al., 1998; Shirayama et
al., 1998). This complicates the in vivo analysis of the pro-
teolysis of these proteins because of the possibility that ec-
topic expression of these proteins during half-life measure-
ments could itself alter APC/C function (Amon, 1997).
Ase1p is a microtubule-binding and cross-linking protein
that is required for the structural integrity of the anaphase
spindle (Juang et al., 1997; unpublished data). Although
Ase1p is not expected to regulate APC/C, high levels of
Ase1p activate the spindle assembly checkpoint and thereby
might indirectly affect APC/C activity (Juang et al., 1997;
for review see Amon, 1999). To create an inert reporter of
APC
 
Cdh1
 
 activity, we constructed chimeras between Ase1p
and glutathione 
 
S
 
-transferase (GST). These chimeras en-
abled us to define the minimal Ase1p sequence necessary for
APC
 
Cdh1
 
-mediated degradation. The half-lives of the GST–
Ase1p fusions were measured in 
 

 
-factor–arrested cells (Fig.
2 A). A chimera containing the COOH-terminal 254 amino
acids (R632-I885) of Ase1p was degraded with similar ki-
netics to full-length Ase1p. Further deletions up to amino
acid 802 from the COOH-terminal end of R632-I885 were
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also rapidly degraded in 
 

 
-factor–arrested cells. By contrast,
deletion of 22 amino acids on the NH
 
2
 
-terminal side of the
R632-I885 peptide resulted in a stable chimera (T654-I885;
Fig. 2 A). 7 of these 22 residues are lysines, raising the possi-
bility that these may be the site(s) of Ase1p ubiquitination.
Together, these results suggest that residues 632–802 com-
 
prise the minimal sequence for Ase1p degradation in 
 

 
-fac-
tor–arrested cells.
The degradation of the GST–R632-I885 fusion protein
(hereafter referred to as C254) was characterized in more de-
tail and found to have the characteristics of a bona fide
APC
 
Cdh1
 
 substrate. Like wild-type Ase1p, C254 degradation
in 
 

 
-factor–arrested cells required Cdc23p and hence APC/
C function (Fig. 2 B). C254 degradation in 
 

 
-factor–
arrested cells also required the Ase1p destruction box and
Cdh1p but was not affected by loss of Cdc20p (data not
shown). Also, like wild-type Ase1p this fusion was stable in
both S and G2/M phase–arrested cells (data not shown). Fi-
nally, as shown above for wild-type Ase1p, C254 was rapidly
degraded in 
 
cdc4
 
-arrested cells, and this degradation re-
quired the db and Cdh1p (Fig. 2, C and D). Thus, the deg-
radation of C254 closely mimics that of Ase1p.
The localization of full-length Ase1p is restricted to the
spindle midzone (the zone of overlap between the two half-
spindles) (Pellman et al., 1995). By contrast, the C254 fu-
sion protein localized diffusely throughout the nucleus and
as expected did not complement an 
 
ase1
 

 
 mutation (Fig. 2
E; data not shown). Therefore, the specific localization of
Ase1p on the mitotic spindle is not required for the normal
timing of its degradation.
The finding that Ase1p was degraded by APC
 
Cdh1
 
 at the
 
cdc4
 
 block suggested that G1 CDK activity was not suffi-
cient to fully inactivate APC
 
Cdh1
 
. To monitor APC
 
Cdh1
 
 activ-
ity during a normal cell cycle, C254 was expressed from the
 
GALL
 
 promoter (Mumberg et al., 1994), a derivative of the
 
GAL1,10
 
 promoter that is transcribed at low levels through-
out the cell cycle when cells are grown in galactose-contain-
ing medium. Importantly, constitutive expression of C254
did not affect cell growth (data not shown) or cell cycle pro-
gression (Fig. 3 A). Because transcription of C254 from this
promoter was constant during the cell cycle (Fig. 3 B), the
steady-state level of C254 protein reflected its degradation.
Analysis of C254 levels in synchronized cells suggested
that APC
 
Cdh1
 
 is inactivated during S phase. Wild-type cells
expressing C254 were released from a G1 block, and C254
levels were determined at intervals after release. Cell cycle
position was monitored by Sic1p degradation, which occurs
at the G1/S transition (Schwob et al., 1994), by the level of
histone 2B mRNA, which is induced at S phase onset (Here-
ford et al., 1981), and by FACS
 
®
 
 analysis. We found that
C254 accumulated after Sic1p was degraded, when histone
2B mRNA peaked and when FACS
 
®
 
 analysis demonstrated
that cells had entered S phase (Fig. 3 B).
Because APC
 
Cdh1
 
 appeared to be inactivated during S
phase, we determined if removal of Clb5p, the major S
phase cyclin (Epstein and Cross, 1992; Schwob and Na-
smyth, 1993), would affect the accumulation of C254. Con-
sistent with a role for Clb5p in APC
 
Cdh1
 
 inactivation, C254
accumulation was delayed by 
 

 
10 min in a 
 
clb5
 

 
 strain
(Fig. 3 C). By contrast, deletion of 
 
CLB3
 
 and 
 
CLB4
 
, which
encode M phase cyclins, had no effect on the timing of
C254 destruction (data not shown). Therefore, the normal
timing of APC
 
Cdh1
 
 inactivation requires Clb5p.
We considered the possibility that ectopic expression of
Clb2p could overcome the high levels of Sic1p in late G1-
Figure 1. APCCdh1 is active in late G1. (A) cdc4 strains containing 
GAL1,10::ASE1 or GAL1,10::ASE1-DB (Juang et al., 1997) were ar-
rested in yeast extract and peptone (YEP) raffinose at 36C. Expres-
sion from the GAL1,10 promoter was induced for 60 min, and the 
half-life of Ase1p or Ase1p-db was determined. G1 arrest was con-
firmed by FACS®. (B) The half-life of Ase1p was determined in ar-
rested cdc4 cdh1 clb6 and cdc4 CDH1 clb6 strains as above. 
The clb6 mutation was introduced into these strains to promote ef-
ficient arrest. cdc4 cdh1 double mutants arrest poorly in late G1, 
probably because of persistent low levels of B-type cyclins from the 
previous mitosis (unpublished data). (C) cdc4 strains containing an 
epitope-tagged APC/C subunit (Cdc16p-myc6), or the untagged 
control, and HA-tagged Cdh1p (HA3-Cdh1p) were arrested at 36C, 
and APC/C was immunoprecipitated using a monoclonal antibody 
directed against the myc epitope. Extracts and immunoprecipitates 
were probed with 12CA5 to detect HA3-Cdh1p.
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Figure 2. Ase1p domain sufficient for APCCdh1-mediated degrada-
tion. (A) Stability of Ase1p NH2-terminal truncations fused to GST in 
-factor–arrested cells. Chimeras were expressed from the GALL 
promoter for 30 min in -factor–arrested cells, and the half-lives of 
the chimeras were assayed. R632-I885 is the COOH-terminal 254 
amino acids of Ase1p. (B) CDC23 and cdc23-1 strains containing 
GAL1,10::C254 were arrested with -factor, shifted to 36C for 30 
min to inactivate Cdc23p, then galactose was added for 30 min to 
induce expression of C254, and the half-life of the chimera was de-
termined. (C) cdc4 cells containing C254 or a db mutant of C254 
(C254-db) were arrested at 36C, and the half-lives of the fusion pro-
teins were determined 30 min after the addition of galactose. (D) 
The half-life of C254 was determined in arrested cdc4 cdh1 clb6 
and cdc4 CDH1 clb6 cells. (E) Cells constitutively expressing C254 
(the GST–R632-I885 fusion protein) were prepared for immunofluo-
rescence. No signal was detected in this strain grown under repress-
ing conditions (glucose; data not shown). C254 is diffusely localized 
to the nucleus and appears to be at higher levels in mitotic cells.
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arrested cells and combine with G1 CDK activity to inacti-
vate APCCdh1. This could explain the difference between the
timing of degradation of Ase1p and Clb2p. To test this idea,
cdc4 cells constitutively expressing low levels of Clb2p were
synchronized with -factor and released at 36C to the cdc4
arrest point in the presence or absence of hemagglutinin
(HA)-tagged Sic1p overexpressed from the GAL1,10 pro-
moter (Verma et al., 1997). As expected, Clb2p accumu-
lated in the control culture (Fig. 4 A, glu). However, Clb2p
accumulation was prevented in the Sic1p-overexpressing
culture (Fig. 4, compare F with gal). Northern blot analy-
sis showed that CLB2 mRNA levels did not differ between
the two cultures (Fig. 4 A). We next measured the half-life
of Clb2p in cdc4-arrested cells in the presence or absence of
Sic1p overexpression. In the absence of Sic1p overexpres-
sion, Clb2p has a half-life of 60 min, whereas with coover-
expression of Sic1p, Clb2p half-life is 20 min. FACS®
analysis showed that the cells remained arrested in G1 for
30 min after the samples were collected (Fig. 4 B). To-
gether, our results suggest that a combination of G1 cyclins
and either S phase or M phase cyclins are required to inacti-
vate APCCdh1.
The persistence of APCCdh1 activity through late G1 sug-
gested that the degradation of certain APCCdh1 substrates
might be required for the normal execution of S phase. One
appealing candidate for such a substrate is the APC activator
Figure 3. APCCdh1 activity is inactivated during S phase. (A) Con-
stitutive expression of C254 does not alter the cell cycle. Strains 
constitutively expressing either GST or GST–R632-I885 (C254) from 
the GALL promoter by growth in galactose-containing medium were 
arrested with -factor, collected by filtration, and released into the 
cell cycle. FACS® analysis was performed at the indicated time 
points after release. (B) S phase stabilization of C254. A wild-type 
strain expressing C254 from the GALL promoter was grown in galactose-containing medium and arrested in -factor and released into fresh 
medium. Samples were then collected for Western blotting, Northern blotting, and FACS® analysis at the indicated time points. (C) CLB5 and 
clb5 strains expressing C254 under the control of the GALL promoter were grown in galactose-containing medium, arrested in -factor, re-
leased, and samples collected as in B.
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Cdc20p. Metazoan Cdc20p is an APCCdh1 substrate (Pfleger
and Kirschner, 2000; Sorensen et al., 2000), and premature
activation of APCCdc20 might interfere with the expression of S
phase cyclins. Indeed, we found that degradation of yeast
Cdc20p is APCCdh1 dependent in cdc4-arrested cells (Fig. 5 A).
To test the functional consequences of premature accumu-
lation of Cdc20p during G1, we determined if inappropriate
expression of Cdc20p in G1 affected cell cycle progression
through S phase. Cells expressing Cdc20Box12-HA
from the pGAL1,10 promoter were released into galactose-
containing medium from a G1 block, and cell cycle transit
was monitored by FACS® analysis. By contrast with the con-
trol strain containing vector only, the Cdc20Box12-
expressing strain was delayed in transiting S phase (Fig. 5 B).
Next, we tested whether this delay in transiting S phase is
due to the failure to degrade Cdc20p in G1 by comparing
the cell cycle transit of strains expressing either wild-type
Cdc20p or Cdc20Box12. Compared with the Cdc20p-
expressing strain, the Cdc20Box12 strain was also de-
layed in transiting S phase (Fig. 5 C). This delay correlates
with the amount of Cdc20p that is expressed in G1 because
Cdc20p was expressed at lower levels than Cdc20Box12
until cells reached S phase (Fig. 5 C). These experiments sug-
gest that APCCdh1 activity during G1 helps to ensure the
proper timing of Cdc20p expression and thereby enables S
phase progression to proceed with normal kinetics.
Figure 4. Overexpression of Sic1p in-
creases Clb2p turnover at the cdc4 
block. (A) Overexpression of Sic1 blocks 
Clb2p accumulation at the cdc4 block. 
A cdc4 strain expressing Clb2p-HA3 
from the methionine-repressible MET25 
(Mumberg et al., 1994) promoter and 
Sic1p-HA from the GAL1,10 promoter 
(Verma et al., 1997) were arrested with 
-factor and released at the nonpermis-
sive temperature to arrest at the cdc4 
block. After release, the culture was 
split, and Sic1p-HA expression was in-
duced by the addition of galactose (gal) 
in one culture and repressed in the other 
with glucose (glu). The two cultures 
were kept at 36C, until the cells were 
arrested with elongated buds and G1 
DNA content. The levels of Clb2p-HA3 
and Sic1p-HA were determined by 
Western blotting, and CLB2 mRNA lev-
els were determined by Northern blot-
ting. The MET25 promoter expresses at 
low levels even under the repressing 
conditions of this experiment (medium 
containing methionine). (B) Sic1p over-
expression restores Clb2p degradation in 
cdc4-arrested cells. The strain used in A 
was treated as above, and the half-life of 
Clb2p-HA3 was determined after ex-
pression was shut off by the addition of 
methionine and cycloheximide.
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Discussion
We found that APCCdh1 is inactivated during S phase, and
its complete inactivation requires Clb5p. Both Ase1p and
Cdc20p were degraded in late G1-arrested cells containing
high levels of G1 CDK activity. Cdh1p was required for the
degradation of both substrates. We also found that a fraction
of Cdh1p was bound to the APC/C in late G1-arrested cells.
Further, the S phase cyclin Clb5p was required for the nor-
mal timing of APCCdh1 inactivation. Thus, in a normal cell
cycle the additive activities of G1 and S phase CDKs inacti-
vate APCCdh1. These findings have two implications for the
design of the yeast cell cycle. First, the key role for Clb5p in
APCCdh1 inactivation suggests that Clb5p has an important
role in enabling the expression of mitotic cyclins. This func-
tion was previously ascribed entirely to G1 cyclins. Second,
because Clb5p is degraded by APCCdc20 our finding that
yeast Cdc20p is an APCCdh1 substrate suggests that high
APCCdh1 activity throughout G1 may help ensure that
Clb5p can accumulate sufficiently to drive a normal S phase.
Our conclusions differ from that of previous work using
Clb2p degradation to monitor APCCdh1 activity in vivo. The
prior work suggested that G1 CDKs alone could inactivate
what is now known to be APCCdh1 (Amon et al., 1994). The
difference in the timing of Clb2p, Ase1p and Cdc20p degra-
dation reported here could either be due to intrinsic differ-
ences in how these proteins are recognized by APCCdh1 or to
effects from the ectopic expression of Clb2p. Although we
found that some Cdh1p is bound to APC/C in cdc4-arrested
cells, considerably less is bound than in -factor–arrested
cells. It is therefore possible that APCCdh1 is a more efficient
enzyme for Ase1p and Cdc20p ubiquitination than for
Clb2p ubiquitination. However, we also found that coover-
expression of Sic1p at the cdc4 arrest point blocks Clb2p ac-
cumulation and restores Clb2p degradation in cdc4-arrested
cells. This suggests that ectopic Clb/CDK activity was re-
sponsible for turning off the APCCdh1 in the previous experi-
ments. We therefore favor the idea that both G1- and
B-type cyclin–associated kinases are required to fully inacti-
vate APCCdh1. Clb2p expressed in late G1 could either di-
rectly inactivate the APCCdh1 or compete for Sic1p binding
to S phase cyclins thereby freeing them to inhibit APCCdh1.
How might G1 and S phase CDKs cooperate to inactivate
APCCdh1? Despite the presence of highly phosphorylated
Cdh1p at the cdc4 block, enough APCCdh1 remains for rapid
degradation of Ase1p and Cdc20p. Since Cdh1p has multi-
ple functionally important CDK phosphorylation sites (Za-
chariae et al., 1998; Jaspersen et al., 1999), G1 and S phase
CDK might preferentially phosphorylate different sites or
make an additive contribution to the total level of Cdh1p
phosphorylation. Alternatively, the inhibitory effects of S
phase CDK activity could be through phosphorylation of
another substrate such as subunits of APC (Rudner and
Murray, 2000). Whatever the mechanism for Clb5p-medi-
ated inactivation of APCCdh1, these results identify a novel
Clb5p role in the inactivation of APCCdh1 and by inference
in the accumulation of mitotic cyclins.
These experiments also have implications for the rela-
tionship among Clb5p, APCCdh1, and APCCdc20. In both
the Xenopus extract system and in cells overexpressing hu-
man Cdh1p, APCCdh1 promotes the degradation of human
Cdc20p (Pfleger and Kirschner, 2000; Sorensen et al.,
2000). Our finding that yeast Cdc20p is also degraded by
APCCdh1 in late G1 demonstrates that this regulatory mecha-
nism is conserved. Further, our in vivo experiments suggest
that inappropriate expression of Cdc20p can delay progres-
sion through S phase. Therefore, we propose that the follow-
ing regulation occurs at the G1/S transition. APCCdh1 is ac-
tive throughout G1. Clb5p accumulates in late G1, but
Clb5/CDK activity is held in check by the presence of Sic1p
(Schwob et al., 1994). After Sic1p is degraded, Clb5/CDK
activity drives DNA replication and inactivates APCCdh1. Be-
cause Cdc20p is an APCCdh1 substrate, APCCdh1 activity en-
sures that no Cdc20p is present to activate APCCdc20 until
after Clb5/CDK is active. It should be emphasized that
degradation of Cdc20p by APCCdh1 is one of several controls
on Cdc20p expression as CDC20 transcription is also low in
G1 (Prinz et al., 1998; Shirayama et al., 1998). Additionally,
full APCCdc20 activation also appears to require the phos-
phorylation of the APC/C itself (Kotani et al., 1999; Shtein-
berg et al., 1999; Kramer et al., 2000; Rudner and Murray,
2000). The existence of multiple overlapping control mecha-
nisms is a common theme in the regulation of cell cycle tran-
sitions. We make the analogy to the regulation of mitotic exit
where proteolysis, decreased transcription, and the expression
of an inhibitor all collaborate to shut off mitotic cyclins.
Finally, our findings impact on the physiological role
of Clb5p degradation by APCCdc20. Mutant cells lacking
Cdc20p but able to separate sister chromatids (cdc20
pds1 strains) cannot exit from mitosis (Shirayama et al.,
1999). However, these cells are able to exit mitosis if CLB5
is deleted. Based on these findings, it was suggested that
Cdc20p promotes mitotic exit in a normal cell cycle by de-
grading Clb5p, which in turn releases inhibition of Sic1p
and Cdh1p. The results presented here raise the possibility
that the role of Clb5p degradation in mitotic exit is indirect
and occurs by suppression of mitotic cyclins. In the absence
of Clb5p, APCCdh1 may remain partially active, resulting in
decreased levels of the mitotic cyclins Clb1p and Clb2p. In
cells with reduced levels of mitotic cyclins, APCCdh1 alone
may be sufficient to trigger mitotic exit. The latter model is
consistent with the established role of mitotic cyclin proteol-
ysis in mitotic exit.
The APC/C is strikingly conserved among eukaryotes.
The conservation of the APC/C is seen not only in the pep-
tide sequence of its components and substrates but also ex-
tends to aspects of its regulation. Our results highlight what
may be a general role for S phase cyclins in regulating
APCCdh1. In human cells, the S phase cyclin A complexed to
Cdk1p phosphorylates and inactivates Cdh1p during S
phase (Lukas et al., 1999). Thus, S phase inactivation of
APCCdh1 appears to be a conserved mechanism for control of
the cell cycle.
Materials and methods
Strains and microbial techniques
Media and genetic techniques were as described (Sherman et al., 1986). To
arrest cells in late G1, cdc4-1 cells were shifted to 36C until 90% of cells
showed either multiple or elongated buds. To arrest cells in S or G2/M
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phase, hydroxyurea or nocodazole was added to a final concentration of
10 mg/ml or 15 g/ml, respectively. To arrest cells in early G1, -factor
was added to a final concentration of 100 nM for sst1 strains and 5 M for
SST1 strains. To release cells from -factor arrest, cells were collected by
filtration, washed, and resuspended in fresh medium. All strains were de-
rivatives of W303 except the A364-derived clb5 (a gift from F. Cross, The
Rockefeller University, New York, NY) and CLB5 control strains in Fig. 3 C.
Mutagenesis and cloning
DNA manipulations were performed as described (Sambrook et al., 1989).
Ase1p truncations were generated by PCRs. The sequence of the oligonu-
cleotide primers used for PCR are available upon request. All PCR-gener-
ated constructs were verified by DNA sequencing.
Half-life determination
Cells were arrested in medium containing 3% raffinose; galactose was
added to a final concentration of 3% for 30–60 min, and then glucose (fi-
nal concentration 3%) and cycloheximide (final concentration 1 mg/ml)
were added to shut off transcription and translation. For proteins expressed
from the MET25 promoter, methionine (final concentration 1 mM) and cy-
cloheximide were added. Protein samples were prepared from cells col-
lected at the indicated time points and analyzed by Western blotting.
Protein extracts were made as described (Yaffe and Schatz, 1984).
Immunoblots were developed using ECL. Ase1p and derivatives were de-
tected with either 9E10 (Evan et al., 1985) for myc-tagged proteins or a
rabbit polyclonal anti-Ase1p antibody (Juang et al., 1997). myc-tagged
Cdc16p was detected with 9E10. HA-tagged Clb2p, Cdh1p, and Cdc20p
were detected with the 12CA5 monoclonal antibody (Field et al., 1988).
Polyclonal antibodies were used to detect -tubulin (Serotec), 	-tubulin (a
gift from F. Solomon, Massachusetts Institute of Technology, Cambridge,
MA), and Sic1p (a gift from J.W. Harper, Baylor College of Medicine,
Houston, TX). For quantification in Fig. 4, immunoblots were developed
with ECL, fluorescence was detected using StormImager (Molecular Dy-
namics), and signal intensities were measure using ImageQuant 5.0 soft-
ware. For quantification in Fig. 5, immunoblots were probed with an
IRDye800 fluorescent-labeled secondary antibody and quantitated on the
Odyssey Infrared Imaging System (Li-Cor); fluorescence between blots was
normalized to reference standards that were loaded on both blots.
Figure 5. APCCdh1 regulation of Cdc20p expression. (A) 
Cdc20p is an APCCdh1 substrate in late G1. Expression of HA-
tagged Cdc20p from the GAL1,10 promoter (Prinz et al., 
1998) was induced for 40 min, and the half-life of Cdc20p 
was determined in arrested cdc4 cdh1 clb6 and cdc4 
CDH1 clb6 strains as for Ase1p in the legend to Fig. 1 B. (B) 
Expression of stable Cdc20p in G1 delays S phase progres-
sion. Wild-type strains containing either vector alone or 
GAL1,10::Cdc20Box12-HA (Prinz et al., 1998) were ar-
rested with -factor in YEP raffinose 3%. Expression from the 
GAL1,10 promoter was induced for 30 min, and then cells 
were washed and released into YEP galactose 3%. (C) Inabil-
ity to degrade Cdc20p in G1 delays S phase progression. 
Wild-type strains containing either GAL1,10::Cdc20-HA or 
GAL1,10::Cdc20Box12-HA (Prinz et al., 1998) were ar-
rested with -factor in YEP raffinose 3%. Expression from the 
GAL1,10 promoter was induced for 15 min, and then cells 
were washed and released into YEP galactose 2%. The levels 
of the HA-tagged Cdc20p and Cdc20Box12 were deter-
mined by Western blotting and quantified as described in 
Materials and methods.
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Immunoprecipitation
Strains containing myc-tagged Cdc16p (or untagged control) and HA-
tagged Cdh1p were arrested at either 36C (-factor, cdc4) or 24C (no-
codazole). Cells were lysed using glass beads in IP buffer (50 mM Hepes,
pH 7.3, 150 mM potassium acetate, 10 mM sodium fluoride, 1 mM EDTA,
1 mM PMSF, 20 mM 	-glycerophosphate, 1 mM sodium vanadate, Phos-
phatase Inhibitor sets I and II [Calbiochem], 0.1% Triton X-100, and Com-
plete™ protease inhibitors [Roche]). Extracts (2–4 mg) were incubated with
9E10 monoclonal antibodies (1,000:1) in IP buffer for 2 h at 4C. Anti-
body-bound extracts were then incubated with protein G–plus agarose
beads (Calbiochem) for 4 h at 4C in IP buffer. The beads were washed five
times with IP buffer and resuspended in sample buffer. Bound proteins
were analyzed by SDS-PAGE and immunoblotting.
Flow cytometry
Cells were prepared for FACS® analysis as described (Pellman et al., 1995)
and analyzed on a FACScan™ using CellQuest software (Becton Dickin-
son).
Northern blotting
RNA preparation, Northern blot analysis, and the probes to detect histone
2B1 and actin mRNA were as described (Pellman et al., 1995). The probe
for ASE1 mRNA was a 1.2-kb fragment from nucleotides 1896–3108 of the
ASE1 locus (where 1 is the A residue of the ATG codon).
Immunofluorescence
Cells were fixed and prepared for DAPI staining and immunofluorescence
as described previously (Pringle et al., 1991). C254 containing three
COOH-terminal myc tags was detected with 9E10.
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